Protective Effectiveness of Hantavirus Vaccine

Abstract

A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.

Keywords

• hantavirus vaccine
• hemorrhagic fever with renal syndrome
• effectiveness
• dispatch
• South Korea